BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31783581)

  • 1. Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma.
    Hsu TN; Huang CM; Huang CS; Huang MS; Yeh CT; Chao TY; Bamodu OA
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAT1 Upregulates in Oral Squamous Cell Carcinoma and Promotes Cell Proliferation
    Lan T; Ge Q; Zheng K; Huang L; Yan Y; Zheng L; Lu Y; Zheng D
    Front Oncol; 2022; 12():870055. PubMed ID: 35646625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts.
    Chen JH; Wu ATH; Bamodu OA; Yadav VK; Chao TY; Tzeng YM; Mukhopadhyay D; Hsiao M; Lee JC
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of β-catenin.
    Nishikawa Y; Miyazaki T; Nakashiro K; Yamagata H; Isokane M; Goda H; Tanaka H; Oka R; Hamakawa H
    Oncol Rep; 2011 Sep; 26(3):587-92. PubMed ID: 21617878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
    Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance.
    Alam M; Kashyap T; Mishra P; Panda AK; Nagini S; Mishra R
    Head Neck; 2019 Jan; 41(1):185-197. PubMed ID: 30549344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
    Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
    Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FAT1 inhibits cell proliferation of esophageal squamous cell carcinoma through regulating the expression of CDK4/CDK6/CCND1 complex].
    Hu XL; Zhai YF; Li GD; Xing JF; Yang J; Bi YH; Wang J; Shi RY
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):14-20. PubMed ID: 29365412
    [No Abstract]   [Full Text] [Related]  

  • 13. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
    Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
    Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
    Gao J; Ulekleiv CH; Halstensen TS
    J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy.
    Li S; Wu Y; Ding Y; Yu M; Ai Z
    J Cell Physiol; 2018 Dec; 233(12):9416-9425. PubMed ID: 30054909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma.
    Hu X; Zhai Y; Shi R; Qian Y; Cui H; Yang J; Bi Y; Yan T; Yang J; Ma Y; Zhang L; Liu Y; Li G; Zhang M; Cui Y; Kong P; Cheng X
    Oncol Rep; 2018 May; 39(5):2136-2146. PubMed ID: 29565465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
    Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
    Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANKRD2 expression combined with TNFRSF19 expression for evaluating the prognosis of oral squamous cell carcinoma patients.
    Yao S; Xiao H; Wei C; Chen S
    Heliyon; 2024 Jan; 10(1):e24091. PubMed ID: 38234906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.